18F-FDG与68Ga-DOTATATE PET/CT显示转移性嗜铬细胞瘤与肺腺癌共存
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
PubMed 文献 · Clin Nucl Med · 2019-01-01
本文报告一例60岁男性复发性转移性嗜铬细胞瘤与肺腺癌共存患者的18F-FDG和68Ga-DOTATATE PET/CT表现。转移性嗜铬细胞瘤在两种显像中均显示活性增高,而肺腺癌病灶未见明显DOTATATE活性。
要点
- 转移性嗜铬细胞瘤在18F-FDG和68Ga-DOTATATE PET/CT上均活性增高。
- 肺腺癌病灶在68Ga-DOTATATE PET/CT上未见明显活性。
- 双显像剂PET/CT有助于区分嗜铬细胞瘤转移与共存肿瘤。
核心结论
- 复发性转移性嗜铬细胞瘤与肺腺癌共存时,转移性嗜铬细胞瘤在18F-FDG和68Ga-DOTATATE PET/CT上均活性增高,而肺腺癌病灶未见明显DOTATATE活性。
研究设计与样本
- 病例报告:一例60岁男性复发性转移性嗜铬细胞瘤与肺腺癌共存患者,行18F-FDG和68Ga-DOTATATE PET/CT显像。
主要发现
- 转移性嗜铬细胞瘤在18F-FDG和68Ga-DOTATATE PET/CT上均显示活性增高。
- 肺腺癌病灶在68Ga-DOTATATE PET/CT上未见明显活性。
临床怎么用
- 对嗜铬细胞瘤患者评估时,若18F-FDG与68Ga-DOTATATE PET/CT表现不一致,需考虑共存其他肿瘤的可能。
局限性
- 本文为单例病例报告,结论的普遍适用性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Both F-FDG and Ga-DOTATATE PET/CT are used in the evaluation of pheochromocytomas. We reported F-FDG and Ga-DOTATATE PET/CT findings in a 60-year-old man who had recurrent metastatic pheochromocytoma coexisting with lung adenocarcinoma. The metastatic pheochromocytoma showed increased activity on both F-FDG and Ga-DOTATATE PET/CT, whereas the lung adenocarcinoma lesion showed no obvious DOTATATE activity.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Cheng Z, Zou S, Song S, et al. Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images. Clin Nucl Med. 2019. PMID: 31021913. doi:10.1097/RLU.0000000000002588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。